Infectious Disease Research, Infection Prevention & Hospital Epidemiology
Dr. Philip Robinson is board certified by the American Board of Internal Medicine in Infectious Disease with over 30 years of experience. Dr. Robinson currently serves as the Medical Director of Infection Prevention and Hospital Epidemiology, as well as the Chair of the Antimicrobial Stewardship Programs at Hoag Memorial Hospital Presbyterian and Hoag Orthopedic Institute in Orange County, California.
He is focusing on infection prevention and clinical research related to the development of therapeutics and vaccinations, serving as the principal investigator for over 25 infectious disease related clinical trials.
Research & Publications
In partnership with Hoag Hospital, Dr. Robinson's clinical research interests include infection prevention, antimicrobial stewardship, vaccine development, laboratory diagnostics and therapeutics.
Education
Infectious Disease Fellowship, 1993 - 1995
University of Southern California/LAC+USC Medical Center
Internal Medicine Internship and Residency, 1990-1993
Harbor - UCLA Medical Center
Medical School, 1985-1990
Michigan State University College of Human Medicine
Certifications & Honors
ABIM Certified Diplomat in Infectious Disease, 1996—2026
SHEA/CDC/AMDA Infection Prevention in Post-Acute & Long Term Care Certificate Course, Atlanta, Georgia, May 2016
SHEA/CDC Training Courses in Healthcare Epidemiology, 1996, 2009, 2015, 2022
Lean Green Belt Certificate, Institute of Industrial Engineers, 2012
Affiliations
Infectious Disease Association of California (Past President), 2018 - Present
Infectious Disease Association of California (Governing Board), 2011 - Present
Infectious Disease Association of California (Member), 1998 - Present
Infectious Disease Society of America, 1994 - Present
Society for Healthcare Epidemiology of America, 1994 - Present
Outpatient Clinical Research Opportunities
Now Enrolling Outpatients for a Clinical Trial
RECOVER clinical trials will explore possible treatments for symptoms that Long COVID patients reported to affect their quality of life the most. To be considered from enrollment, please call 949-764-4577. If there is no answer, please leave a message and someone will return your call.
THE E.MBRACE STUDY will assess the efficacy and safety of an investigational vaccine in the prevention of urine and blood infections in adults 60 years of age or older. To be considered for enrollment, click on this link, put in your zip code and select Hoag Medical Group as your study site.
ACTIV-6 is no longer enrolling. Click on this link to review the results of this study.